NFAT promotes carcinoma invasive migration through glypican-6

Biochemical Journal

Volumn 440, Issue 1, 2011, Pages 157-166

  Yiu, Gary K ^a   Kaunisto, Aura ^a   Chin, Y Rebecca ^a   Toker, Alex ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Cancer invasion; Glypican; Nuclear factor of activated t cells (NFAT); Transcription factor

Indexed keywords

BETA CATENIN; GLYPICAN; MITOGEN ACTIVATED PROTEIN KINASE P38; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR NFAT; WNT PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER INVASION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION;

BETA CATENIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GLYPICANS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NFATC TRANSCRIPTION FACTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; TRANSCRIPTIONAL ACTIVATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 80054942842     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110530     Document Type: Article

References (50)

1. Hogan, P. G., Chen, L., Nardone, J. and Rao, A. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232 (Pubitemid 37128637)
2. Crabtree, G. R. and Olson, E. N. (2002) NFAT signaling: choreographing the social lives of cells. Cell 109, S67-S79 (Pubitemid 34457853)
3. Mancini, M. and Toker, A. (2009) NFAT proteins: emerging roles in cancer progression. Nat. Rev. Cancer 9, 810-820
4. Rao, A., Luo, C. and Hogan, P. G. (1997) Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747 (Pubitemid 27169297)
5. Macian, F. (2005) NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5, 472-484
6. Robbs, B. K., Cruz, A. L., Werneck, M. B., Mognol, G. P. and Viola, J. P. (2008) Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol.Cell. Biol. 28, 7168-7181
7. Ferrara, N., Gerber, H. P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676 (Pubitemid 36749215)
8. Nagy, J. A., Dvorak, A. M. and Dvorak, H. F. (2007) VEGF-A and the induction of pathological angiogenesis. Annu. Rev. Pathol. 2, 251-275 (Pubitemid 46448066)
9. Ryeom, S., Baek, K. H., Rioth, M. J., Lynch, R. C., Zaslavsky, A., Birsner, A., Yoon, S. S. and McKeon, F. (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell 13, 420-431 (Pubitemid 351609439)
10. Baek, K. H., Zaslavsky, A., Lynch, R. C., Britt, C., Okada, Y., Siarey, R. J., Lensch, M. W., Park, I. H., Yoon, S. S., Minami, T. et al. (2009) Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459, 1126-1130
11. Jauliac, S., Lopez-Rodriguez, C., Shaw, L. M., Brown, L. F., Rao, A. and Toker, A. (2002) The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat. Cell Biol. 4, 540-544 (Pubitemid 34752442)
12. Chen, M. and O'Connor, K. L. (2005) Integrin α6β4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. Oncogene 24, 5125-5130 (Pubitemid 41129090)
13. Liu, S., Umezu-Goto, M., Murph, M., Lu, Y., Liu, W., Zhang, F., Yu, S., Stephens, L. C., Cui, X., Murrow, G. et al. (2009) Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15, 539-550
14. Yiu, G. K. and Toker, A. (2006) NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J. Biol. Chem. 281, 12210-12217 (Pubitemid 43855303)
15. Veugelers, M., De Cat, B., Ceulemans, H., Bruystens, A. M., Coomans, C., Durr, J., Vermeesch, J., Marynen, P. and David, G. (1999) Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J. Biol. Chem. 274, 26968-26977
16. Wee, S., Wiederschain, D., Maira, S. M., Loo, A., Miller, C., de Beaumont, R., Stegmeier, F., Yao, Y. M. and Lengauer, C. (2008) PTEN-deficient cancers depend on PIK3CB. Proc. Nat. Acad. Sci. U.S.A. 105, 13057-13062
17. Yiu, G. K. and Hecht, N. B. (1997) Novel testis-specific protein-DNA interactions activate transcription of the mouse protamine 2 gene during spermatogenesis. J. Biol. Chem. 272, 26926-26933 (Pubitemid 27452643)
18. Northrop, J. P., Ullman, K. S. and Crabtree, G. R. (1993) Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J. Biol. Chem. 268, 2917-2923 (Pubitemid 23057929)
19. Capurro, M. I., Xiang, Y. Y., Lobe, C. and Filmus, J. (2005) Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res. 65, 6245-6254 (Pubitemid 40994410)
20. Stigliano, I., Puricelli, L., Filmus, J., Sogayar, M. C., Bal de Kier Joffe, E. and Peters, M. G. (2009) Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation. Breast Cancer Res. Treat. 114, 251-262
21. Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L. et al. (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7, 793-803
22. Song, H. H., Shi, W., Xiang, Y. Y. and Filmus, J. (2005) The loss of glypican-3 induces alterations in Wnt signaling. J. Biol. Chem. 280, 2116-2125
23. Pukrop, T., Klemm, F., Hagemann, T., Gradl, D., Schulz, M., Siemes, S., Trumper, L. and Binder, C. (2006) Wnt5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc. Nat. Acad. Sci. U.S.A. 103, 5454-5459
24. Weeraratna, A. T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M. and Trent, J. M. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1, 279-288 (Pubitemid 41039152)
25. Yamanaka, H., Moriguchi, T., Masuyama, N., Kusakabe, M., Hanafusa, H., Takada, R., Takada, S. and Nishida, E. (2002) JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep. 3, 69-75 (Pubitemid 34144818)
26. Paine-Saunders, S., Viviano, B. L. and Saunders, S. (1999) GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13. Genomics 57, 455-458 (Pubitemid 29239237)
27. Matsuda, K., Maruyama, H., Guo, F., Kleeff, J., Itakura, J., Matsumoto, Y., Lander, A. D. and Korc, M. (2001) Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res. 61, 5562-5569 (Pubitemid 32694943)
28. Su, G., Meyer, K., Nandini, C. D., Qiao, D., Salamat, S. and Friedl, A. (2006) Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. Am. J. Pathol. 168, 2014-2026 (Pubitemid 43825320)
29. Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Buchler, M. W., Lander, A. D. and Korc, M. (1998) The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J. Clin. Invest. 102, 1662-1673 (Pubitemid 28516251)
30. Kleeff, J., Wildi, S., Kumbasar, A., Friess, H., Lander, A. D. and Korc, M. (1999) Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Pancreas 19, 281-288 (Pubitemid 29445002)
31. Li, J., Kleeff, J., Kayed, H., Felix, K., Penzel, R., Buchler, M. W., Korc, M. and Friess, H. (2004) Glypican-1 antisense transfection modulates TGF-β-dependent signaling in Colo-357 pancreatic cancer cells. Biochem. Biophys. Res. Commun. 320, 1148-1155 (Pubitemid 38916663)
32. Yamanaka, K., Ito, Y., Okuyama, N., Noda, K., Matsumoto, H., Yoshida, H., Miyauchi, A., Capurro, M., Filmus, J. and Miyoshi, E. (2007) Immunohistochemical study of glypican 3 in thyroid cancer. Oncology 73, 389-394 (Pubitemid 351862032)
33. Midorikawa, Y., Ishikawa, S., Iwanari, H., Imamura, T., Sakamoto, H., Miyazono, K., Kodama, T., Makuuchi, M. and Aburatani, H. (2003) Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer. 103, 455-465 (Pubitemid 36020219)
34. Nakatsura, T., Kageshita, T., Ito, S., Wakamatsu, K., Monji, M., Ikuta, Y., Senju, S., Ono, T. and Nishimura, Y. (2004) Identification of glypican-3 as a novel tumor marker for melanoma. Clin. Cancer Res. 10, 6612-6621 (Pubitemid 39346558)
35. Baumhoer, D., Tornillo, L., Stadlmann, S., Roncalli, M., Diamantis, E. K. and Terracciano, L. M. (2008) Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am. J. Clin. Pathol. 129, 899-906
36. Toretsky, J. A., Zitomersky, N. L., Eskenazi, A. E., Voigt, R. W., Strauch, E. D., Sun, C. C., Huber, R., Meltzer, S. J. and Schlessinger, D. (2001) Glypican-3 expression in Wilms tumor and hepatoblastoma. J. Pediatr. Hematol. Oncol. 23, 496-499 (Pubitemid 33123699)
37. Peters, M. G., Farias, E., Colombo, L., Filmus, J., Puricelli, L. and Bal de Kier Joffe, E. (2003) Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. Breast Cancer Res. Treat. 80, 221-232 (Pubitemid 36886511)
38. Xiang, Y. Y., Ladeda, V. and Filmus, J. (2001) Glypican-3 expression is silenced in human breast cancer. Oncogene 20, 7408-7412 (Pubitemid 33078211)
39. Campos-Xavier, A. B., Martinet, D., Bateman, J., Belluoccio, D., Rowley, L., Tan, T. Y., Baxova, A., Gustavson, K. H., Borochowitz, Z. U., Innes, A. M. et al. (2009) Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia. Am. J. Hum. Genet. 84, 760-770
40. Lau, C. S., Yu, C. B., Wong, H. K., Fan, D. S., Mak, H. T., Wong, K. W., Lam, D. S., Pang, C. P. and Choy, K. W. (2010) Allelic imbalance at 13q31 is associated with reduced GPC6 in Chinese with sporadic retinoblastoma. Br. J. Ophthalmol. 94, 357-362
41. Capurro, M. I., Xu, P., Shi, W., Li, F., Jia, A. and Filmus, J. (2008) Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev. Cell 14, 700-711 (Pubitemid 351622615)
42. 2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1α signaling in human mammary epithelial cells. Mol. Cell. Biol. 26, 6024-6036
43. Ripka, S., Konig, A., Buchholz, M., Wagner, M., Sipos, B., Kloppel, G., Downward, J., Gress, T. and Michl, P. (2007) WNT5A: target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28, 1178-1187 (Pubitemid 47062676)
44. Fernandez-Cobo, M., Zammarchi, F., Mandeli, J., Holland, J. F. and Pogo, B. G. (2007) Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells. Oncol. Rep. 17, 903-907
45. Yamamoto, H., Kitadai, Y., Yamamoto, H., Oue, N., Ohdan, H., Yasui, W. and Kikuchi, A. (2009) Laminin γ2 mediates Wnt5a-induced invasion of gastric cancer cells. Gastroenterology 137, 242-252
46. Imamichi, Y., Waidmann, O., Hein, R., Eleftheriou, P., Giehl, K. and Menke, A. (2005) TGFβ-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4. Biol. Chem. 386, 225-236 (Pubitemid 40485428)
47. McMurtry, V., Simeone, A. M., Nieves-Alicea, R. and Tari, A. M. (2009) Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin. Exp. Metastasis 26, 197-204
48. Whyte, J., Bergin, O., Bianchi, A., McNally, S. and Martin, F. (2009) Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res. 11, 209
49. Chang, J., Sonoyama, W., Wang, Z., Jin, Q., Zhang, C., Krebsbach, P. H., Giannobile, W., Shi, S. and Wang, C. Y. (2007) Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J. Biol. Chem. 282, 30938-30948 (Pubitemid 350035235)
50. 2+ non-canonical pathway. J. Biol. Chem. 282, 28980-28990